Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Mann

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Science Translational Medicine|March 29, 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functionsPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Cell Reports|July 21, 2021
An intranasal vaccine durably protects against SARS-CoV-2 variants in miceAhmed O Hassan, Swathi Shrihari, Matthew J Gorman, et al.
Antiviral Research|March 20, 2023
SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse modelRubens Prince Dos Santos Alves, Ying-Ting Wang, Zbigniew Mikulski, et al.
Research Square|February 23, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationGalit Alter, Matthew Gorman, Nita Patel, et al.
Frontiers in Immunology|June 19, 2026
A proteome-wide atlas of humoral immunity to <i>Mycobacterium tuberculosis</i> across the spectrum of diseaseMehak Z Khan, Edward B Irvine, Deniz Cizmeci, et al.
Nature Immunology|June 15, 2023
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19Paulina Kaplonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Cell Reports. Medicine|September 6, 2021
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Science (New York, N.Y.)|September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyKathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Science Translational Medicine|March 29, 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functionsPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Cell Reports|July 21, 2021
An intranasal vaccine durably protects against SARS-CoV-2 variants in miceAhmed O Hassan, Swathi Shrihari, Matthew J Gorman, et al.
Antiviral Research|March 20, 2023
SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse modelRubens Prince Dos Santos Alves, Ying-Ting Wang, Zbigniew Mikulski, et al.
Research Square|February 23, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationGalit Alter, Matthew Gorman, Nita Patel, et al.
Frontiers in Immunology|June 19, 2026
A proteome-wide atlas of humoral immunity to <i>Mycobacterium tuberculosis</i> across the spectrum of diseaseMehak Z Khan, Edward B Irvine, Deniz Cizmeci, et al.
Nature Immunology|June 15, 2023
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19Paulina Kaplonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Cell Reports. Medicine|September 6, 2021
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Science (New York, N.Y.)|September 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyKathryn M Hastie, Haoyang Li, Daniel Bedinger, et al.
Pageof 2